Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet.
Vickers SP, Cheetham SC, Headland KR, Dickinson K, Grempler R, Mayoux E, Mark M, Klein T. Vickers SP, et al. Among authors: grempler r. Diabetes Metab Syndr Obes. 2014 Jul 1;7:265-75. doi: 10.2147/DMSO.S58786. eCollection 2014. Diabetes Metab Syndr Obes. 2014. PMID: 25061325 Free PMC article.
Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis.
Grempler R, Zibrova D, Schoelch C, van Marle A, Rippmann JF, Redemann N. Grempler R, et al. Diabetes. 2007 Sep;56(9):2235-41. doi: 10.2337/db06-1660. Epub 2007 Jun 27. Diabetes. 2007. PMID: 17596404
27 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page